PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|945-950

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-01, pp. : 945-950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Disposition in Cystic Fibrosis

By Rey E.   Tréluyer J-M.   Pons G.  

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Emerging drug treatments for cystic fibrosis

By Zeitlin Pamela L  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite

Emerging drug treatments for cystic fibrosis

By Zeitlin Pamela L  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 523-535

Informa Healthcare

Access to resources Recommend Favorite

Progress in structure-based drug design against influenza A virus

By Du Qi-Shi   Wei Hang   Huang Ri-Bo   Chou Kuo-Chen  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 619-631

Informa Healthcare

Access to resources Recommend Favorite

Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis: Progress to Date

By Becq Frédéric  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 241-259

Adis International

Access to resources Recommend Favorite